Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders

Published:
September 19, 2023
Written by

View More News

BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

January 29, 2025

BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

Former CSO of Trilo Therapeutics and Research Fellow atAbbVie joins to lead BioLoomics’ pipeline and combine lysosome targetingantibodies with ADCs

January 29, 2025
View News Article